Variables | All (n = 45) |
Type, n (%) |
|
HD | 6 (13.3) |
HDF | 22 (48.9) |
HD/HDF | 17 (37.8) |
Dialysis duration, mo | 34.3 ± 10.8 |
Vascular access, n (%) |
|
Catheter | 28 (62.2) |
AVF | 17 (37.8) |
KT/V | 1.2 ± 0.2 |
IDWG, Kg | 1.9 ± 0.4 |
RD, mL/day | 338.8 ± 36.6 |
>500 | 6 (20.7) |
200 - 400 | 12 (41.4) |
<200 | 11 (37.9) |
EPO, n (%) | 45 (100) |
EPO dosing, IU/Kg/week | 11,187.8 ± 2450.5 |
IV iron therapy, n (%) | 41 (91.1) |
IV Iron dosing, mg/week | 130.6 ± 46.7 |
Financial support, n (%) |
|
Patient/family | 8 (17.8) |
Private and public entreprises | 35 (77.8) |
Government | 2 (4.4) |